StockVS

Materialise NV (MTLS) Stock Analysis

Technology

Materialise NV

$6.19

+$0.29 (+4.92%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Materialise NV functions as a provider of additive manufacturing and medical software tools alongside 3D printing services, serving a global footprint that spans the Americas, Europe, Africa, and the Asia-Pacific region. The enterprise operates within the Technology sector, specifically classified under the Software - Application industry, which implies a business model focused on intellectual property, licensing, and digital solutions rather than traditional hardware manufacturing. The company currently maintains a market capitalization of $305.39M and generates annual revenue of $267.63M, while its employee count is listed as N/A in available records. These valuation and revenue figures indicate that Materialise NV is a mid-sized enterprise with a significant presence in niche technological markets, suggesting a specialized operational scale that balances high-revenue generation with a relatively modest market valuation relative to its top-line performance.

Financial Health

Materialise NV reported revenue of $267.63M over the trailing twelve months, with a net income of $7.72M and an EBITDA of $30.64M. The substantial gap between the $267.63M in revenue and the $7.72M in net income reveals a cost structure where operating expenses and taxes consume approximately 97% of gross sales before reaching the bottom line, leaving a profit margin of only 2.9%. The company recorded free cash flow of $-1,316,000, indicating a period of negative liquidity generation that suggests ongoing capital expenditure or working capital requirements are outpacing cash inflows from operations. Analyzing the margin profile, the gross margin stands at 57.1%, reflecting the high value of software and technology products, while the operating margin is 4.4% and the profit margin is 2.9%, indicating that significant operating costs are necessary to sustain the business model. On the balance sheet, the company holds $133.92M in cash against $63.11M in debt, resulting in a debt-to-equity ratio of 24.70, which presents a mixed picture of strong liquidity reserves but a high leverage ratio relative to equity. The current ratio is 2.43, demonstrating that the company possesses 2.43 times the liquid assets required to cover its short-term obligations, thereby indicating robust short-term liquidity despite the high debt-to-equity figure. Return on Equity is 3.1% and Return on Assets is 1.4%, metrics that reveal management effectiveness is currently constrained by the scale of the asset base and the level of leverage, resulting in low absolute returns on invested capital.

Valuation Assessment

The trailing twelve-month P/E ratio is 33.00, while the forward P/E is 16.83, a significant disparity that implies the market expects earnings growth to be substantial enough to more than halve the valuation multiple in the near term. The price-to-book ratio is 0.99, suggesting the company trades at approximately one times its book value, which indicates the market is not currently applying a significant premium over the net asset value of the firm. Alternative valuation metrics include a price-to-sales ratio of 1.14 and an EV/EBITDA of 7.23, figures that suggest the stock is priced reasonably relative to its sales volume and earnings power before interest, taxes, depreciation, and amortization. The 52-week high is $6.80 and the 52-week low is $3.93, meaning the current trading environment allows for assessment of where the stock sits relative to its annual volatility range without specific current price data provided to calculate the exact percentage deviation. The beta value is 1.23, which indicates that the stock price volatility is 23% higher than the broader market, suggesting the asset will likely experience amplified price swings compared to the overall market index.

Growth & Income

Materialise NV has demonstrated revenue growth of 6.8% year-over-year and earnings growth of 112.8% year-over-year, indicating that earnings are expanding at a rate nearly double that of revenue, which often implies improving margins or one-time gains impacting the bottom line. As the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it retains all generated earnings to reinvest into growth initiatives, R&D, and capital expansion rather than distributing cash to shareholders. The absence of a dividend yield and the zero payout ratio confirm that the capital allocation strategy prioritizes internal reinvestment over shareholder returns. The overall growth and income profile is characterized by double-digit earnings expansion supported by single-digit revenue growth, funded entirely by retained earnings given the lack of a dividend program.

Peer Comparison

Materialise NV (MTLS) operates in the Software - Application industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Materialise NV MTLS $344.08M 29.5
SAP SE SAP $206.49B 24.1
Shopify Inc. SHOP.TO $188.02B 102.8
Salesforce, Inc. CRM $146.50B 22.9

The Software - Application industry average P/E ratio is 45.6x. Materialise NV trades at a P/E of 29.5.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Materialise NV

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Visit website →

Key Statistics

Market Cap
$344.08M
P/E Ratio
29.50
52-Week High
$6.80
52-Week Low
$4.78
Avg Volume
93.88K
Beta
1.28

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
Belgium
Employees
2,556